- CVS Health (NYSE:CVS) initiated with Outperform rating and $95 (14% upside) price target by RBC Capital Markets saying the company is at an inflection point in its life cycle and should merge with a managed care organization.
- Charles River Laboratories (NYSE:CRL) initiated with Sector Perform rating with a $110 (3% upside) price target by RBC Capital Markets citing valuation.
- AmerisourceBergen (NYSE:ABC) initiated with Sector Perform rating and $87 (7% upside) price target by RBC citing the need for more clarity that generic drug pricing has bottomed.
- Allscripts (NASDAQ:MDRX) initiated with Outperform rating and $17 (24% upside) price target by RBC citing positive business execution, positioning for next-generation HCIT solutions and accretion from EIS acquisition.
- Mirati Therapeutics (NASDAQ:MRTX) initiated with Outperform rating by Oppenheimer.
- Express Scripts (NASDAQ:ESRX) initiated with Sector Perform rating and $68 (10% upside) price target by RBC citing the transition of Anthem's business and valuation.
- Walgreens Boots Alliance (NASDAQ:WBA) initiated with Outperform rating and $96 (16% upside) price target by RBC citing improved execution, volume growth and accelerating EPS.
- Cardinal Health (NYSE:CAH) initiated with Sector Perform rating and $72 (7% upside) price target by RBC citing the need for more clarity that generic drug pricing has bottomed.
- athenahealth (NASDAQ:ATHN) initiated with Sector Perform rating and $153 (20% upside) price target by RBC citing valuation.
- Athenex (NASDAQ:ATNX) initiated with Buy rating and $36 price target by Laidlaw.
- Patterson Companies (NASDAQ:PDCO) initiated with Sector Perform rating and $42 (11% upside) price target by RBC citing the need for improved execution and valuation.
- McKesson (NYSE:MCK) initiated with Sector Perform rating and $168 (14% upside) price target by RBC citing valuation and issues relating to drug pricing.
- Henry Schein (NASDAQ:HSIC) initiated with Sector Perform rating and $91 (12% upside) price target by RBC citing valuation.
- Source: Bloomberg
- Now read: ALR's Stock Of The Week: The Cheapest Healthcare Stock?
Original article